Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Hair loss after surgery is temporary and linked to iron deficiency, needing nutritional monitoring.

EMT and metabolic pathways help cancer cells resist treatment and spread.

Glibenclamide slows breast cancer cell growth by stopping cell division.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

Lack of functional CYLD in mice leads to early aging and cancer.

Vitexin shows promise as a cancer treatment by affecting key cellular processes and pathways.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Targeting SOX proteins may improve cancer treatment by restoring immune function.

Targeting LGR4 may help treat cancer by reducing cancer stem cell traits and drug resistance.

Cold Atmospheric Plasma shows promise in treating aggressive breast cancer by targeting cancer cells while sparing normal tissue.

Repurposing existing drugs can improve cancer treatment but faces challenges.

St. John's wort skin oil may increase skin damage risk during radiotherapy.

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

Sun-exposed skin shows different cell activity and gene expression, suggesting targets to prevent skin aging and cancer.

Microneedles show promise for cancer diagnosis and treatment due to their minimally invasive nature and effective drug delivery.

ONCO-NK-TRANSITION-GM1 is a low-cost, effective cancer treatment with a high cure rate and no severe side effects.

ONCO-NK-TRANSITION-GM1 is a low-cost, effective cancer treatment with a high cure rate and no severe side effects.

Repurposing existing drugs and using micronutrients may effectively target cancer stem cells and improve cancer treatment.

Scaffold-based drug delivery systems improve oral cancer treatment by targeting drugs directly to cancer cells, reducing side effects.

A new method, iSiMPRe, effectively identifies key protein regions in cancer genes, highlighting potential drug targets.

β-Sitosterol may help prevent heart disease, cancer, and diabetes, but more human studies are needed.

Cinobufacin with chemotherapy improves treatment response and quality of life in advanced breast cancer patients while reducing some side effects.

Natural compounds may help treat advanced papillary thyroid cancer by targeting specific molecular pathways.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

Nanotechnology improves CRISPR-Cas9 delivery for cancer treatment, but challenges remain.

Synthetic curcumin derivatives improve treatment for diabetes and cancer.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

CXXC5 can both suppress and promote cancer, making it a complex target for treatment.

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.

Targeting specific molecular pathways may improve treatments for chemoresistant cancers.